Sallie R. Permar
- Virology top 0.5%
- HIV Research and Treatment 81
- Infectious Diseases top 0.5%
- HIV/AIDS Research and Interventions 41
- Parvovirus B19 Infection Studies 26
- SARS-CoV-2 and COVID-19 Research 16
- Epidemiology top 1%
- Cytomegalovirus and herpesvirus research 83
- Herpesvirus Infections and Treatments 46
- Virology and Viral Diseases 16
- Immunology top 2%
- Immune Cell Function and Interaction 18
- Obstetrics and Gynecology top 2%
- Co-authors
- Genevieve G. FoudaGeeta K. SwamyDavid R. MartinezMark R. SchleissZhonghe SunYing ZhangJennifer A. JenksYouyi Fong
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Sallie R. Permar
197 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 170
- Virology 808
- Infectious Diseases 1.7k
- Epidemiology 2.2k
- Immunology 1.2k
- Obstetrics and Gynecology 325
Countries citing papers authored by Sallie R. Permar
This map shows the geographic impact of Sallie R. Permar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sallie R. Permar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sallie R. Permar more than expected).
Fields of papers citing papers by Sallie R. Permar
This network shows the impact of papers produced by Sallie R. Permar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sallie R. Permar. The network helps show where Sallie R. Permar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sallie R. Permar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 12 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 16 | |
| 5 | 2024 | 2 | |
| 6 | 2022 | 5 | |
| 7 | 2022 | 6 | |
| 8 | 2021 | 19 | |
| 9 | 2021 | 6 | |
| 10 | 2021 | 21 | |
| 11 | 2020 | 44 | |
| 12 | 2020 | 4 | |
| 13 | 2020 | 12 | |
| 14 | 2019 | 13 | |
| 15 | 2019 | 52 | |
| 16 | 2018 | 10 | |
| 17 | 2018 | 121 | |
| 18 | 2018 | 25 | |
| 19 | 2017 | 79 | |
| 20 | 2010 | 20 |
About Sallie R. Permar
Sallie R. Permar is a scholar working on Virology, Infectious Diseases and Epidemiology, having authored 204 papers that have together received 4.6k indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (83 papers), HIV Research and Treatment (81 papers), Herpesvirus Infections and Treatments (46 papers), HIV/AIDS Research and Interventions (41 papers), Parvovirus B19 Infection Studies (26 papers), Immune Cell Function and Interaction (18 papers), SARS-CoV-2 and COVID-19 Research (16 papers) and Virology and Viral Diseases (16 papers). The work is most often cited by research in Virology (808 citations), Infectious Diseases (1.7k citations) and Epidemiology (2.2k citations). Sallie R. Permar has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Genevieve G. Fouda, Geeta K. Swamy, David R. Martinez, Mark R. Schleiss, Zhonghe Sun, Ying Zhang, Jennifer A. Jenks, Youyi Fong, Cody S. Nelson and Norman L. Letvin. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.